Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines
Abstract Background Although trastuzumab and anthracyclines are frequently used to treat breast cancer (BC) and gastric cancer (GC), cardiotoxicity is a serious concern. The cardiac function assessment is recommended at baseline before initiating treatment. However, the prevalence rates of baseline...
Main Authors: | Taisuke Ishii, Tomone Watanabe, Takahiro Higashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4929 |
Similar Items
-
Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients
by: Taisuke Ishii, et al.
Published: (2023-02-01) -
Effects of Exercise on Cardiac Function Outcomes in Women Receiving Anthracycline or Trastuzumab Treatment for Breast Cancer: A Systematic Review and Meta-Analysis
by: Pedro Antunes, et al.
Published: (2021-09-01) -
An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study
by: Jukapun Yoodee, et al.
Published: (2021-08-01) -
Epidemiology and practice patterns for male breast cancer compared with female breast cancer in Japan
by: Taisuke Ishii, et al.
Published: (2020-08-01) -
Reduction of subclinical acute cardiac injury through DIBH radiotherapy: a single-institution real-world clinical cohort analysis
by: Kun Zhang, et al.
Published: (2025-02-01)